CTI BioPharma Corp.


Updates from The Motley Fool

Latest updates on CTI BioPharma from Fool.com.  The Fool has written over 100 articles on CTI BioPharma.
3 Stocks to Get on Your Watchlist

I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. W...

This Week in Biotech

With the  SPDR S&P Biotech Index  up 43% over the trailing-12-month period, it's evident that inv...



Stock Performance

View Interactive CTIC Charts
Sponsored by

Key Data Points

Primary metrics and data points about CTI BioPharma.
Current Price: $0.48
Prev Close: $0.44
Open: $0.55
Bid: $0.50
Ask: $0.58
Day's Range: $0.45 - $0.58
52wk Range: $0.25 - $1.34
Volume: 6,882,656
Avg Vol 506,536
Market Cap: $73M
P/E (ttm): -1.64
EPS (ttm): ($0.27)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about CTI BioPharma.
CAPS Rating 2 out of 5
 
242 Outperform
41 Underperform
CAPS All Stars
 
16 Outperform
13 Underperform

How do you think CTI BioPharma will perform against the market?



You pick for CTI BioPharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

James A. Bianco, CEO

52% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for CTI BioPharma.

CTI BioPharma Corp.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers